Cantor Fitzgerald Maintains Overweight on SI-BONE, Lowers Price Target to $25
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Ross Osborn has maintained an Overweight rating on SI-BONE (NASDAQ:SIBN) but lowered the price target from $30 to $25.
November 07, 2023 | 4:32 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Cantor Fitzgerald has maintained an Overweight rating on SI-BONE but lowered the price target from $30 to $25.
The news is directly about SI-BONE and is likely to impact its stock price. While the Overweight rating is positive, the lowering of the price target may have a neutral to slightly negative impact on the stock's short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100